Botulinum Toxin and the Treatment of Headache: A Clinical Review

Authors


  • Disclaimer: The author was an investigator in PREEMPT II and is a trainer and speaker for Allergan. This paper could not do justice to the amount of work and all the studies of BT published. Where possible, specific studies were cited. This was not meant to criticize or highlight any particular authors or protocols. For purposes of completeness, the author recommends to the reader studies cited in the bibliography and directly in the text.

A.G. Finkel, Carolina Headache Institute, 103 Market Street, Chapel Hill, NC 27516, USA, email: finkela@carolinaheadacheinstitute.com

Ancillary